Zahra Sheikh

Dr. Zahra Sheikh

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2023 in Life
Verified
Journal Article
Open access
PDF file
AHAhsan Hussain
Ahsan Hussain
ZSZahra Sheikh
Zahra Sheikh
Manju L. SubramanianManju L. Subramanian
Manju L. Subramanian
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder impacting cognition, function, and behavior in the elderly population. While there are currently no disease-modifying agents capable of curing AD, early diagnosis and management in the preclinical stage can significantly improve patient morbidity and life expectancy. Currently, the diagnosis of Alzheimer’s disease is a clinical one, often supplemented by invasive and expensive biomarker testing. Over the last decade, significant advancements have been made in our understanding of AD and the role of ocular tissue as a potential biomarker. Ocular biomarkers hold the potential to provide noninvasive and easily accessible diagnostic and monitoring capabilities. This review summarizes current research for detecting biomarkers of Alzheimer’s disease in ocular tissue.

26 November 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
MPMinali Prasad
Minali Prasad
DGDeniz Goodman
Deniz Goodman
SGSanhit Gutta
Sanhit Gutta
ZSZahra Sheikh
Zahra Sheikh
HCHoward J Cabral
Howard J Cabral
Manju L. SubramanianManju L. Subramanian
Manju L. Subramanian
Background/Objectives: Retinal vascular occlusions, such as retinal vein occlusion (RVO) and retinal artery occlusion (RAO), are associated with cognitive impairment, including dementia. Our objective was to examine the odds of dementia among patients with retinal vascular occlusion. Methods: This cross-sectional study included 474 patients with retinal vascular occlusion and 948 patients without retinal vascular occlusion (comparison group). Patients in the comparison group were age- and sex-matched to those with vascular occlusion. Logistic regression was used to analyze the odds of all-cause dementia, vascular dementia, and Alzheimer’s disease after adjusting for demographic, clinical, and ophthalmic covariates. Main outcome measures included the presence of all-cause dementia, vascular dementia, and Alzheimer’s disease. Results: Patients with RVO (n = 413) had increased odds for all-cause dementia (odds ratio (OR) = 2.32; 95% confidence interval (CI): 1.44–3.75; p < 0.001) and vascular dementia (OR = 3.29; 95% CI: 1.41–7.68; p = 0.006) relative to the comparison group. Patients with central RVO (n = 192) (OR = 2.32; 95% CI: 1.19–4.54; p = 0.014) or branch RVO (n = 221) (OR = 2.68; 95% CI: 1.30–5.50; p = 0.007) had increased odds for all-cause dementia relative to the comparison group. Patients with RAO (n = 61) did not have increased odds of all-cause dementia (OR = 1.01; 95% CI: 0.32–3.26; p = 0.983), vascular dementia (OR = 1.54; 95% CI: 0.22–10.81; p = 0.663), or Alzheimer’s disease (OR = 0.32; 95% CI: 0.05–2.20; p = 0.244). Conclusions: A history of any RVO is associated with increased rates of all-cause dementia and vascular dementia independent of shared cardiovascular risk factors. These associations are not seen with a history of RAO, or between any subtype of vascular occlusions and Alzheimer’s disease.